Skip to main content
. 2016 Jul 12;7(32):51626–51639. doi: 10.18632/oncotarget.10539

Figure 3. Establishment and validation of patient-derived cells (PDCs) from 138T muscle-invasive bladder cancer (MIBC).

Figure 3

(A) The establishment of PDCs from 138T MIBC tissues. The tissues were dissociated into single cells for in-vitro drug screening using a high-throughput screening (HTS) system. Scale bars: 100 μm. (B) Representative confocal microscopy images of immunofluorescence staining of cytokeratin (CK) 7, pan-CK, CK 20, and desmin in 138T PDCs. Scale bars, 100 μm. Red: indicated protein. Blue: DAPI.